| Literature DB >> 26800694 |
Dilbar Aibibu1, Martin Hild2, Michael Wöltje2, Chokri Cherif2.
Abstract
In this article, the benefits offered by micro-fibrous scaffold architectures fabricated by textile manufacturing techniques are discussed: How can established and novel fiber-processing techniques be exploited in order to generate templates matching the demands of the target cell niche? The problems related to the development of biomaterial fibers (especially from nature-derived materials) ready for textile manufacturing are addressed. Attention is also paid on how biological cues may be incorporated into micro-fibrous scaffold architectures by hybrid manufacturing approaches (e.g. nanofiber or hydrogel functionalization). After a critical review of exemplary recent research works on cell-free fiber based scaffolds for in situ TE, including clinical studies, we conclude that in order to make use of the whole range of favors which may be provided by engineered fibrous scaffold systems, there are four main issues which need to be addressed: (1) Logical combination of manufacturing techniques and materials. (2) Biomaterial fiber development. (3) Adaption of textile manufacturing techniques to the demands of scaffolds for regenerative medicine. (4) Incorporation of biological cues (e.g. stem cell homing factors).Entities:
Mesh:
Substances:
Year: 2016 PMID: 26800694 PMCID: PMC4723636 DOI: 10.1007/s10856-015-5656-3
Source DB: PubMed Journal: J Mater Sci Mater Med ISSN: 0957-4530 Impact factor: 3.896
Fig. 1Scaffold development approach based on the requirement of the target cell niche
Fig. 2Engineering process of fibrous architectures as templates for TE/in situ TE applications. Image source: a [46], b [47], c [48], d [49], e [50], f [51], g courtesy of TU Dresden
Fig. 3Examples for biomedical fiber development. Schematic of device for the fabrication of endless collagen filament by electrochemical alignment (a), electrochemically aligned collagen (ELAC) fibers (b), twisted thread (c) and pin-woven scaffold made of ELAC fibers (d, e); Chitosan fibers (f), non-woven (g), knitted (h) and woven (i). a–e from Ref. [80], f–i from [51]
Fig. 4a Engineering process of multimodal nerve conduit based on a tubular knit coated with electrospun nanofibers and incorporated with aligned guidance fibers [63]. b Scaffold design based on the requirements of different implantation sites: Hydrogels incorporating bFGF localized to the bone tunnels, collagen wrapping in the joint cavity [146]. c Hybrid vascular scaffold made of wet-spun microfibers and electrospun nanofibers; manufacturing scheme, photographs and SEM images of scaffolds [64, 147]
| Targeted application | Materials/manufacturing techniques | Function of fibrous structure | Biological cues/clinical application | References |
|---|---|---|---|---|
| Knitting | ||||
| Vascular grafts | PGA knitted fibers + | Initial reinforcement; | – | [ |
| Knitted polyester; commercially available vascular grafts | Mechanical stability | Fibronectin SDF-1 alpha | [ | |
| Knitted PGA/collagen microsponge + woven PLLA (outer layer) | Outer layer: reinforcement; inner layer: porous environment promoting in situ cellularization | – | [ | |
| Knitted PLGA (90:10) + collagen microsponge | Mechanical stability | – | [ | |
| Nerve regeneration | Aligned PLGA fibers + alginate hydrogel contained in knitted PLA sheath coated with electrospun PLA nanofibers | Mechanical stability; | Neurothropic factors (NT-3 or BDNF with LIF, SMDF and MGF-1) | [ |
| Dermal grafts | Warp-knitted PLGA-mesh + collagen/chitosan sponge | Mechanical stability | – | [ |
| Tendon regeneration | Knitted silk + collagen sponge | Mechanical stability; | SDF-1 alpha | [ |
| Esophagus replacement | Porous collagen + PCL knitting, tubularized by sutures | Mechanical stability | – | [ |
| Hernia repair | PLGA (90:10) knit + collagen sponge | Mechanical stability | – | [ |
| Small joint reconstruction | Knitted poly-L/D-lactide (P(L/D)LA) 96/4 | Porous environment for cell ingrowth; | Clinical study | [ |
| Calvarial bone healing | Knitted P(L/D)LA 96/4 | Mechanical stability | FGF-1 | [ |
| Weaving | ||||
| Nerve regenerattion | Biodegradable glass fabric | Mechanical stability | – | [ |
| Vascular graft | Woven tubes (luminal Ø 4 mm), with double-layered PGA (core)/PLLA (sheath) fibers + collagen microsponges | Mechanical stability; | – | [ |
| Fascia replacement/hernia repair | Handwoven meshes from native dragline silk of Nephila spp. | Mechanical stability | – | [ |
| Tendon/Ligament repair | Layered PLLA fabrics; side A: smooth surface, side B: pile-finished surface | Mechanical stability; | – | [ |
| Woven PLA pad | Mechanical stability | – | [ | |
| Woven PLA (commercially available material) | Mechanical stability; Host tissue deposition | – | [ | |
| Braiding | ||||
| Nerve regeneration | PGA tube + collagen sponge | Mechanical stability | Clinical studies | [ |
| Braid of PLLA and PGA yarns (1:1) + collagen coating | Mechanical stability; | – | [ | |
| Microbraided PLGA (10:90) tubes | Mechanical stability | – | [ | |
| Tendon/ligament repair | Lyophilized human fascia reinforced by braided PLLA/PGA fibers | Mechanical stability | – | [ |
| PLLA braid + gelatin hydrogel + collagen membrane | Mechanical stability | bFGF | [ | |
| PLLA 3D square braid | Mechanical stability; | – | [ | |
| Non-woven | ||||
| Nerve regeneration | poly[(R)-3-hydroxybutyrate] (PHB) non-woven | Mechanical stability | Clinical study | [ |
| Oriented silk-fibroin filaments | Mechanical stability; | – | [ | |
| Cartilage repair | PGA felt + hyaluronic acid/hyaluronan | Mechanical stability; | Allogeneic/autologous serum | [ |
| Tendon/ligament repair | PGA sheet | Mechanial stability; | – | [ |
| Chitin sheet | Mechanial stability; | – | [ | |